Skip to main content
Top
Published in: Discover Oncology 1/2024

Open Access 01-12-2024 | Research

Circular RNA COL1A1 promotes Warburg effect and tumor growth in nasopharyngeal carcinoma

Authors: ZeJun Zhou, Fang Xu, Tao Zhang

Published in: Discover Oncology | Issue 1/2024

Login to get access

Abstract

Objective

Circular RNAs (circRNAs), pivotal in the pathogenesis and progression of nasopharyngeal carcinoma (NPC), remain a significant point of investigation for potential therapeutic interventions. Our research was driven by the objective to decipher the roles and underlying mechanisms of hsa_circ_0044569 (circCOL1A1) in governing the malignant phenotypes and the Warburg effect in NPC.

Methods

We systematically collected samples from NPC tissues and normal nasopharyngeal epithelial counterparts. The expression levels of circCOL1A1, microRNA-370-5p (miR-370-5p), and prothymosin alpha (PTMA) were quantitatively determined using quantitative polymerase chain reaction (qPCR) and Western blotting. Transfections in NPC cell lines were conducted using small interfering RNAs (siRNAs) or vectors carrying the pcDNA 3.1 construct for overexpression studies. We interrogated the circCOL1A1/miR-370-5p/PTMA axis's role in cellular functions through a series of assays: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide for cell viability, colony formation for growth, Transwell assays for migration and invasion, and Western blotting for protein expression profiling. To elucidate the molecular interactions, we employed luciferase reporter assays and RNA immunoprecipitation techniques.

Results

Our investigations revealed that circCOL1A1 was a stable circRNA, highly expressed in both NPC tissues and derived cell lines. A correlation analysis with clinical pathological features demonstrated a significant association between circCOL1A1 expression, lymph node metastasis, and the tumor node metastasis staging system of NPC. Functionally, silencing circCOL1A1 led to substantial suppression of cell proliferation, migration, invasion, and metabolic alterations characteristic of the Warburg effect in NPC cells. At the molecular level, circCOL1A1 appeared to modulate PTMA expression by acting as a competitive endogenous RNA or 'sponge' for miR-370-5p, which in turn promoted the malignant characteristics of NPC cells.

Conclusion

To conclude, our findings delineate that circCOL1A1 exerts its oncogenic influence in NPC through the modulation of the miR-370-5p/PTMA signaling axis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765–77.PubMedCrossRef Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765–77.PubMedCrossRef
2.
4.
go back to reference Pei S, Ma C, Chen J, Hu X, Du M, Xu T, et al. CircFOXM1 acts as a ceRNA to upregulate SMAD2 and promote the progression of nasopharyngeal carcinoma. Mol Genet Genomic Med. 2022;10(5): e1914.PubMedPubMedCentralCrossRef Pei S, Ma C, Chen J, Hu X, Du M, Xu T, et al. CircFOXM1 acts as a ceRNA to upregulate SMAD2 and promote the progression of nasopharyngeal carcinoma. Mol Genet Genomic Med. 2022;10(5): e1914.PubMedPubMedCentralCrossRef
5.
6.
go back to reference Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33.PubMedPubMedCentralCrossRef Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33.PubMedPubMedCentralCrossRef
7.
go back to reference Locasale JW, Vander Heiden MG, Cantley LC. Rewiring of glycolysis in cancer cell metabolism. Cell Cycle. 2010;9(21):4253.PubMedCrossRef Locasale JW, Vander Heiden MG, Cantley LC. Rewiring of glycolysis in cancer cell metabolism. Cell Cycle. 2010;9(21):4253.PubMedCrossRef
8.
go back to reference Johar D, Elmehrath AO, Khalil RM, Elberry MH, Zaky S, Shalabi SA, et al. Protein networks linking Warburg and reverse Warburg effects to cancer cell metabolism. BioFactors. 2021;47(5):713–28.PubMedCrossRef Johar D, Elmehrath AO, Khalil RM, Elberry MH, Zaky S, Shalabi SA, et al. Protein networks linking Warburg and reverse Warburg effects to cancer cell metabolism. BioFactors. 2021;47(5):713–28.PubMedCrossRef
9.
go back to reference Tyagi K, Mandal S, Roy A. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: a promise towards disease remission. Biochim Biophys Acta Rev Cancer. 2021;1876(1): 188563.PubMedCrossRef Tyagi K, Mandal S, Roy A. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: a promise towards disease remission. Biochim Biophys Acta Rev Cancer. 2021;1876(1): 188563.PubMedCrossRef
10.
go back to reference Zhao Y, Yang L, He J, Yang H. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma. Tumour Biol. 2017;39(7):1010428317711644.PubMedCrossRef Zhao Y, Yang L, He J, Yang H. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma. Tumour Biol. 2017;39(7):1010428317711644.PubMedCrossRef
11.
go back to reference Zhao P, Zhou M, Chen R, Su R. Suppressed, “Warburg Effect” in nasopharyngeal carcinoma via the inhibition of pyruvate kinase type M2-mediated energy generation pathway. Technol Cancer Res Treat. 2020;19:1533033820945804.PubMedPubMedCentralCrossRef Zhao P, Zhou M, Chen R, Su R. Suppressed, “Warburg Effect” in nasopharyngeal carcinoma via the inhibition of pyruvate kinase type M2-mediated energy generation pathway. Technol Cancer Res Treat. 2020;19:1533033820945804.PubMedPubMedCentralCrossRef
12.
go back to reference Su Y, Yu QH, Wang XY, Yu LP, Wang ZF, Cao YC, et al. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression. BMC Cancer. 2017;17(1):477.PubMedPubMedCentralCrossRef Su Y, Yu QH, Wang XY, Yu LP, Wang ZF, Cao YC, et al. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression. BMC Cancer. 2017;17(1):477.PubMedPubMedCentralCrossRef
13.
go back to reference Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, et al. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:38.PubMedPubMedCentralCrossRef Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, et al. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:38.PubMedPubMedCentralCrossRef
14.
go back to reference Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18.PubMedCrossRef Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18.PubMedCrossRef
15.
go back to reference Li W, Xu R, Zhu B, Wang H, Zhang H, Hu L, et al. Circular RNAs: functions and mechanisms in nasopharyngeal carcinoma. Head Neck. 2022;44(2):494–504.PubMedCrossRef Li W, Xu R, Zhu B, Wang H, Zhang H, Hu L, et al. Circular RNAs: functions and mechanisms in nasopharyngeal carcinoma. Head Neck. 2022;44(2):494–504.PubMedCrossRef
16.
go back to reference Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–325.PubMedCrossRef Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–325.PubMedCrossRef
17.
go back to reference Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79.PubMedPubMedCentralCrossRef Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79.PubMedPubMedCentralCrossRef
19.
go back to reference Xia L, Song M, Sun M, Wang F, Yang C. Circular RNAs as biomarkers for cancer. Adv Exp Med Biol. 2018;1087:171–87.PubMedCrossRef Xia L, Song M, Sun M, Wang F, Yang C. Circular RNAs as biomarkers for cancer. Adv Exp Med Biol. 2018;1087:171–87.PubMedCrossRef
20.
21.
go back to reference Zhou M, Zhang P, Zhao Y, Liu R, Zhang Y. Overexpressed circRANBP17 acts as an oncogene to facilitate nasopharyngeal carcinoma via the miR-635/RUNX2 axis. J Cancer. 2021;12(14):4322–31.PubMedPubMedCentralCrossRef Zhou M, Zhang P, Zhao Y, Liu R, Zhang Y. Overexpressed circRANBP17 acts as an oncogene to facilitate nasopharyngeal carcinoma via the miR-635/RUNX2 axis. J Cancer. 2021;12(14):4322–31.PubMedPubMedCentralCrossRef
22.
go back to reference Wang L, Sang J, Zhang Y, Gao L, Zhao D, Cao H. Circular RNA ITCH attenuates the progression of nasopharyngeal carcinoma by inducing PTEN upregulation via miR-214. J Gene Med. 2022;24(1): e3391.PubMedCrossRef Wang L, Sang J, Zhang Y, Gao L, Zhao D, Cao H. Circular RNA ITCH attenuates the progression of nasopharyngeal carcinoma by inducing PTEN upregulation via miR-214. J Gene Med. 2022;24(1): e3391.PubMedCrossRef
23.
go back to reference Ma Y, Ren Y, Wen H, Cui C. circCOL1A1 promotes the progression of gastric cancer cells through sponging miR-145 to enhance RABL3 expression. J Immunol Res. 2021;2021:6724854.PubMedPubMedCentralCrossRef Ma Y, Ren Y, Wen H, Cui C. circCOL1A1 promotes the progression of gastric cancer cells through sponging miR-145 to enhance RABL3 expression. J Immunol Res. 2021;2021:6724854.PubMedPubMedCentralCrossRef
24.
go back to reference Yin L, Chen J, Ma C, Pei S, Du M, Zhang Y, et al. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3. Cell Death Dis. 2020;11(7):562.PubMedPubMedCentralCrossRef Yin L, Chen J, Ma C, Pei S, Du M, Zhang Y, et al. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3. Cell Death Dis. 2020;11(7):562.PubMedPubMedCentralCrossRef
25.
go back to reference Liao M, Liao W, Xu N, Li B, Liu F, Zhang S, et al. LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2. EBioMedicine. 2019;41:200–13.PubMedPubMedCentralCrossRef Liao M, Liao W, Xu N, Li B, Liu F, Zhang S, et al. LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2. EBioMedicine. 2019;41:200–13.PubMedPubMedCentralCrossRef
26.
go back to reference Baker CN, Gidus SA, Price GF, Peoples JN, Ebert SN. Impaired cardiac energy metabolism in embryos lacking adrenergic stimulation. Am J Physiol Endocrinol Metab. 2015;308(5):E402–13.PubMedCrossRef Baker CN, Gidus SA, Price GF, Peoples JN, Ebert SN. Impaired cardiac energy metabolism in embryos lacking adrenergic stimulation. Am J Physiol Endocrinol Metab. 2015;308(5):E402–13.PubMedCrossRef
27.
go back to reference Qiao A, Jin X, Pang J, Moskophidis D, Mivechi NF. The transcriptional regulator of the chaperone response HSF1 controls hepatic bioenergetics and protein homeostasis. J Cell Biol. 2017;216(3):723–41.PubMedPubMedCentralCrossRef Qiao A, Jin X, Pang J, Moskophidis D, Mivechi NF. The transcriptional regulator of the chaperone response HSF1 controls hepatic bioenergetics and protein homeostasis. J Cell Biol. 2017;216(3):723–41.PubMedPubMedCentralCrossRef
28.
go back to reference Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K, et al. Effects of miR-1236-3p and miR-370-5p on activation of p21 in various tumors and its inhibition on the growth of lung cancer cells. Tumour Biol. 2017;39(6):1010428317710824.PubMedCrossRef Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K, et al. Effects of miR-1236-3p and miR-370-5p on activation of p21 in various tumors and its inhibition on the growth of lung cancer cells. Tumour Biol. 2017;39(6):1010428317710824.PubMedCrossRef
29.
go back to reference Zhang Y, Li L, Lu KX, Yu LB, Meng J, Liu CY. LncRNA SNHG3 is responsible for the deterioration of colorectal carcinoma through regulating the miR-370-5p/EZH1 axis. Eur Rev Med Pharmacol Sci. 2021;25(19):6131–7.PubMed Zhang Y, Li L, Lu KX, Yu LB, Meng J, Liu CY. LncRNA SNHG3 is responsible for the deterioration of colorectal carcinoma through regulating the miR-370-5p/EZH1 axis. Eur Rev Med Pharmacol Sci. 2021;25(19):6131–7.PubMed
30.
go back to reference Lee KT, Tan JK, Lam AK, Gan SY. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: a critical review. Crit Rev Oncol Hematol. 2016;103:1–9.PubMedCrossRef Lee KT, Tan JK, Lam AK, Gan SY. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: a critical review. Crit Rev Oncol Hematol. 2016;103:1–9.PubMedCrossRef
31.
go back to reference Fan DC, Zhao YR, Qi H, Hou JX, Zhang TH. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma. Auris Nasus Larynx. 2020;47(4):632–42.PubMedCrossRef Fan DC, Zhao YR, Qi H, Hou JX, Zhang TH. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma. Auris Nasus Larynx. 2020;47(4):632–42.PubMedCrossRef
32.
go back to reference Chen X, Xu W, Ma Z, Zhu J, Hu J, Li X, et al. Circ_0000215 exerts oncogenic function in nasopharyngeal carcinoma by targeting miR-512-5p. Front Cell Dev Biol. 2021;9: 688873.PubMedPubMedCentralCrossRef Chen X, Xu W, Ma Z, Zhu J, Hu J, Li X, et al. Circ_0000215 exerts oncogenic function in nasopharyngeal carcinoma by targeting miR-512-5p. Front Cell Dev Biol. 2021;9: 688873.PubMedPubMedCentralCrossRef
33.
go back to reference Xu XD, Shao SX, Jiang HP, Cao YW, Wang YH, Yang XC, et al. Warburg effect or reverse Warburg effect? A review of cancer metabolism. Oncol Res Treat. 2015;38(3):117–22.PubMedCrossRef Xu XD, Shao SX, Jiang HP, Cao YW, Wang YH, Yang XC, et al. Warburg effect or reverse Warburg effect? A review of cancer metabolism. Oncol Res Treat. 2015;38(3):117–22.PubMedCrossRef
34.
go back to reference Enzo E, Santinon G, Pocaterra A, Aragona M, Bresolin S, Forcato M, et al. Aerobic glycolysis tunes YAP/TAZ transcriptional activity. EMBO J. 2015;34(10):1349–70.PubMedPubMedCentralCrossRef Enzo E, Santinon G, Pocaterra A, Aragona M, Bresolin S, Forcato M, et al. Aerobic glycolysis tunes YAP/TAZ transcriptional activity. EMBO J. 2015;34(10):1349–70.PubMedPubMedCentralCrossRef
35.
go back to reference Liu Z, Liu F, Wang F, Yang X, Guo W. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p. Mol Cell Biochem. 2021;476(1):175–86.PubMedCrossRef Liu Z, Liu F, Wang F, Yang X, Guo W. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p. Mol Cell Biochem. 2021;476(1):175–86.PubMedCrossRef
36.
go back to reference Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, et al. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer. 2021;20(1):112.PubMedPubMedCentralCrossRef Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, et al. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer. 2021;20(1):112.PubMedPubMedCentralCrossRef
37.
40.
go back to reference Yu L, Lu M, Jia D, Ma J, Ben-Jacob E, Levine H, et al. Modeling the genetic regulation of cancer metabolism: interplay between glycolysis and oxidative phosphorylation. Cancer Res. 2017;77(7):1564–74.PubMedPubMedCentralCrossRef Yu L, Lu M, Jia D, Ma J, Ben-Jacob E, Levine H, et al. Modeling the genetic regulation of cancer metabolism: interplay between glycolysis and oxidative phosphorylation. Cancer Res. 2017;77(7):1564–74.PubMedPubMedCentralCrossRef
41.
go back to reference Hsu CC, Peng D, Cai Z, Lin HK. AMPK signaling and its targeting in cancer progression and treatment. Semin Cancer Biol. 2022;85:52–68.PubMedCrossRef Hsu CC, Peng D, Cai Z, Lin HK. AMPK signaling and its targeting in cancer progression and treatment. Semin Cancer Biol. 2022;85:52–68.PubMedCrossRef
42.
go back to reference Theriault JE, Shaffer C, Dienel GA, Sander CY, Hooker JM, Dickerson BC, et al. A functional account of stimulation-based aerobic glycolysis and its role in interpreting BOLD signal intensity increases in neuroimaging experiments. Neurosci Biobehav Rev. 2023;153: 105373.PubMedCrossRef Theriault JE, Shaffer C, Dienel GA, Sander CY, Hooker JM, Dickerson BC, et al. A functional account of stimulation-based aerobic glycolysis and its role in interpreting BOLD signal intensity increases in neuroimaging experiments. Neurosci Biobehav Rev. 2023;153: 105373.PubMedCrossRef
43.
go back to reference Luengo A, Li Z, Gui DY, Sullivan LB, Zagorulya M, Do BT, et al. Increased demand for NAD(+) relative to ATP drives aerobic glycolysis. Mol Cell. 2021;81(4):691-707.e6.PubMedCrossRef Luengo A, Li Z, Gui DY, Sullivan LB, Zagorulya M, Do BT, et al. Increased demand for NAD(+) relative to ATP drives aerobic glycolysis. Mol Cell. 2021;81(4):691-707.e6.PubMedCrossRef
44.
go back to reference Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinform. 2009;7(4):147–54.CrossRef Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinform. 2009;7(4):147–54.CrossRef
45.
go back to reference Gambari R, Brognara E, Spandidos DA, Fabbri E. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol. 2016;49(1):5–32.PubMedPubMedCentralCrossRef Gambari R, Brognara E, Spandidos DA, Fabbri E. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol. 2016;49(1):5–32.PubMedPubMedCentralCrossRef
46.
go back to reference Ma T, Li H, Yang W, Liu Q, Yan H. Over-expression of miR-193a-3p regulates the apoptosis of colorectal cancer cells by targeting PAK3. Am J Transl Res. 2022;14(2):1361–75.PubMedPubMedCentral Ma T, Li H, Yang W, Liu Q, Yan H. Over-expression of miR-193a-3p regulates the apoptosis of colorectal cancer cells by targeting PAK3. Am J Transl Res. 2022;14(2):1361–75.PubMedPubMedCentral
47.
go back to reference Zhu Y, Qi X, Yu C, Yu S, Zhang C, Zhang Y, et al. Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB). Clin Proteomics. 2019;16:12.PubMedPubMedCentralCrossRef Zhu Y, Qi X, Yu C, Yu S, Zhang C, Zhang Y, et al. Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB). Clin Proteomics. 2019;16:12.PubMedPubMedCentralCrossRef
50.
go back to reference Wu CD, Kuo YS, Wu HC, Lin CT. MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. J Biomed Sci. 2011;18(1):80.PubMedPubMedCentralCrossRef Wu CD, Kuo YS, Wu HC, Lin CT. MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. J Biomed Sci. 2011;18(1):80.PubMedPubMedCentralCrossRef
Metadata
Title
Circular RNA COL1A1 promotes Warburg effect and tumor growth in nasopharyngeal carcinoma
Authors
ZeJun Zhou
Fang Xu
Tao Zhang
Publication date
01-12-2024
Publisher
Springer US
Published in
Discover Oncology / Issue 1/2024
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-024-00941-1

Other articles of this Issue 1/2024

Discover Oncology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine